Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 7.47
(-0.53%)
CNY 7.47
(-0.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 41.49 Million | 115.72 Million | 100.78 Million | 44.09 Million | 59.46 Million | 100.37 Million |
| Net Income | 25.1 Million | 45.93 Million | 35.65 Million | -179.36 Million | 7.85 Million | -126.47 Million |
| Depreciation & Amortization | 73.01 Million | 65.82 Million | 61.67 Million | 65.04 Million | 56.09 Million | 52.69 Million |
| Deferred income taxes | -1.22 Million | 667.25 Thousand | 14.86 Thousand | 706.2 Thousand | 285.84 Thousand | -619.74 Thousand |
| Stock-based compensation | 1.54 Million | - | - | - | - | - |
| Change in working capital | -46.3 Million | 8.35 Million | 4.48 Million | 69.47 Million | 5.34 Million | 20.25 Million |
| Other non-cash items | 6.54 Million | -4.39 Million | -1.02 Million | 88.94 Million | -9.82 Million | 153.89 Million |
| Investing Cash Flow | -345.89 Million | -44.44 Million | 142.28 Million | -157.25 Million | 18.85 Million | -343.99 Million |
| Investments in PPE | -219.79 Million | -148.68 Million | -153.44 Million | -17.17 Million | -20.33 Million | -58.37 Million |
| Acquisitions | -51.66 Million | 10.35 Million | 486 Thousand | -295.55 Million | 81.38 Thousand | 1020.00 |
| Investment purchases | -162.45 Million | -70 Million | -100 Million | -350 Million | -955 Million | -1.35 Billion |
| Sales/Maturities of investments | 67.6 Million | 88.06 Million | 41.82 Million | 466.73 Million | 961.78 Million | 1.04 Billion |
| Other Investing Activities | 20.33 Million | 75.82 Million | 353.42 Million | 38.75 Million | 32.32 Million | -285.61 Million |
| Financing Cash Flow | 135 Million | 315.26 Million | -211.32 Million | -3.54 Million | - | -49.62 Million |
| Debt repayment | -133.33 Million | -48 Million | -5.93 Million | - | - | - |
| Dividends payments | -13.76 Million | - | - | -3.54 Million | - | -49.62 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | -2.12 Million | -4.59 Million | - | - | - |
| Other Financing Activities | 17.92 Million | 365.38 Million | -200.8 Million | - | - | - |
| Accounts receivables | -12.04 Million | 6.83 Million | -4.18 Million | 22.28 Million | 72.09 Million | 51.78 Million |
| Accounts payables | -7.72 Million | 996.8 Thousand | 4.54 Million | 28.47 Million | -54.3 Million | -31.04 Million |
| Inventory | -25.32 Million | -147.05 Thousand | 4.1 Million | 18 Million | -12.73 Million | 139.6 Thousand |
| Other working capital | -12.28 Million | 667.25 Thousand | 14.86 Thousand | 706.2 Thousand | 285.83 Thousand | 20.11 Million |
| Cash at beginning of period | 525.05 Million | 138.52 Million | 106.78 Million | 223.48 Million | 145.16 Million | 438.41 Million |
| Cash at end of period | 355.66 Million | 525.05 Million | 138.52 Million | 106.78 Million | 223.48 Million | 145.16 Million |
| Capital Expenditure | -219.79 Million | -148.68 Million | -153.44 Million | -17.17 Million | -20.33 Million | -58.37 Million |
| Effect of forex changes on cash | - | 0.36 | - | - | - | 0.63 |
| Net cash flow / Change in cash | -169.39 Million | 386.53 Million | 31.74 Million | -116.7 Million | 78.32 Million | -293.25 Million |
| Free Cash Flow | -178.3 Million | -32.96 Million | -52.66 Million | 26.91 Million | 39.13 Million | 41.99 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.03 Million | -29.01 Million | 4.29 Million | -54.03 Million | 25.1 Million | 6.09 Million |
| Depreciation & Amortization | - | 17.46 Million | 17.46 Million | 73.01 Million | 73.01 Million | -36.96 Million |
| Deferred income taxes | - | - | - | - | -1.22 Million | - |
| Stock-based compensation | - | - | - | 1.54 Million | 1.54 Million | - |
| Change in working capital | - | - | - | -49.64 Million | -46.3 Million | 53.18 Million |
| Other non-cash items | 27.76 Million | 31.07 Million | 975.42 Thousand | 77.4 Million | 6.54 Million | -32.6 Million |
| Investing Cash Flow | 68.65 Million | -65.11 Million | -192.23 Million | -99.67 Million | -345.89 Million | -71.58 Million |
| Investments in PPE | -15.46 Million | -58.49 Million | -42.71 Million | -59.02 Million | -219.79 Million | -79.01 Million |
| Acquisitions | - | -6.62 Million | 8000.00 | -51.66 Million | -51.66 Million | - |
| Investment purchases | - | - | -159.62 Million | 3.44 Million | -162.45 Million | -9 Million |
| Sales/Maturities of investments | 74.02 Million | 92 Thousand | 10 Million | 13.42 Million | 67.6 Million | 13 Million |
| Other Investing Activities | 10.09 Million | 10 Million | 92 Thousand | -5.92 Million | 20.33 Million | 3.42 Million |
| Financing Cash Flow | -46.08 Million | 34.39 Million | 28.57 Million | -11.72 Million | 135 Million | 92.99 Million |
| Debt repayment | -16.5 Million | -49.8 Million | -29.9 Million | -500 Thousand | -133.33 Million | -67.93 Million |
| Dividends payments | - | -9.64 Million | -1.32 Million | -13.76 Million | -13.76 Million | -824.54 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -29.58 Million | -9.64 Million | -1.32 Million | -9.99 Million | 17.92 Million | 161.75 Million |
| Accounts receivables | - | - | - | -12.04 Million | -12.04 Million | 22.73 Million |
| Accounts payables | - | - | - | - | -7.72 Million | - |
| Inventory | - | - | - | -25.32 Million | -25.32 Million | 30.45 Million |
| Other working capital | - | - | - | -12.28 Million | -12.28 Million | - |
| Cash at beginning of period | 151.16 Million | 197.28 Million | 355.66 Million | 420.32 Million | 525.05 Million | 409.2 Million |
| Cash at end of period | 195.45 Million | 151.16 Million | 197.28 Million | 355.66 Million | 355.66 Million | 420.32 Million |
| Capital Expenditure | -15.46 Million | -58.49 Million | -42.71 Million | -59.02 Million | -219.79 Million | -79.01 Million |
| Effect of forex changes on cash | - | - | - | - | - | -1.40 |
| Net cash flow / Change in cash | 44.29 Million | -46.11 Million | -158.38 Million | -64.65 Million | -169.39 Million | 11.12 Million |
| Free Cash Flow | 6.26 Million | -73.89 Million | -37.44 Million | -12.28 Million | -178.3 Million | -89.3 Million |
603183
6505
7279
6738
WIRTEK
YGRAF